Reorganizations [Abstract]
Reorganization items
Reorganization items [Table Text Block]
The schedule represents a summary of reorganization items.
Payables and Accruals [Abstract]
Bonus
Accrued Bonuses, Current
Professional fees
Accrued Professional Fees, Current
Vacation
Accrued Vacation, Current
Other (primarily R&D vendors and CMOs)
Other Accrued Liabilities, Current
Accrued expenses and other current liabilities
Accrued Liabilities, Current
Property, Plant and Equipment [Abstract]
Leasehold improvements, gross
Leasehold Improvements, Gross
Computer equipment, gross
Computer Equipment
The gross amount of capitalized computer equipment costs as of the balance sheet date.
Furniture and fixtures, gross
Furniture and Fixtures, Gross
Property, plant and equipment, gross
Property, Plant and Equipment, Gross
Accumulated depreciation, depletion and amortization, property, plant, and equipment
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Property, plant and equipment, net
Property, Plant and Equipment, Net
Depreciation and other amortization
Depreciation, Depletion and Amortization
Reorganization Items, net
Reorganization under Chapter 11 of US Bankruptcy Code Disclosure [Text Block]
Accrued Expenses
Accrued expenses and other current liabilities [Text Block]
The entire disclosure for accrued liabilities and other current liabilities at the end of the reporting period.
Research and Development [Abstract]
Procurement Contract and Research Agreements
Procurement Contract and Research Agreements [Text Block]
The entire disclosure for procurement contracts and research agreements including grants or contracts from various agencies of the U.S. government to support the reporting entity's research and development activities.
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments [Table]
Schedule of Long-term Debt Instruments [Table]
Credit Facility [Axis]
Credit Facility [Axis]
Credit Facility [Domain]
Credit Facility [Domain]
Secured Debt
Secured Debt [Member]
Equity Components [Axis]
Equity Components [Axis]
Equity Component [Domain]
Equity Component [Domain]
Warrants
Warrant [Member]
Scenario [Axis]
Scenario [Axis]
Scenario, Unspecified [Domain]
Scenario, Unspecified [Domain]
Forecast
Scenario, Forecast [Member]
Debt Instrument Capacity by Specific Purpose [Axis]
Debt Instrument Capacity by Specific Purpose [Axis]
Debt Instrument Capacity by Specific Purpose [Axis]
Debt Instrument Capacity by Specific Purpose [Domain]
Debt Instrument Capacity by Specific Purpose [Domain]
[Domain] for Debt Instrument Capacity by Specific Purpose [Axis]
Repayment of Interests
Repayment of Interests [Member]
Repayment of Interests [Member]
Payments Related to Litigation
Payments Related to Litigation [Member]
Payments Related to Litigation [Member]
Variable Rate [Axis]
Variable Rate [Axis]
Variable Rate [Domain]
Variable Rate [Domain]
London Interbank Offered Rate (LIBOR)
London Interbank Offered Rate (LIBOR) [Member]
US Treasury Rate
US Treasury Rate [Member]
US Treasury Rate [Member]
Debt Instrument [Axis]
Debt Instrument [Axis]
Debt Instrument, Name [Domain]
Debt Instrument, Name [Domain]
Loan Agreement
Loan Agreement [Member]
Loan Agreement [Member]
Debt Instrument [Line Items]
Debt Instrument [Line Items]
Line of credit facility
Line of Credit Facility, Maximum Borrowing Capacity
Margin for term loan
Debt Instrument, Basis Spread on Variable Rate
Effective interest rate (as a percent)
Debt Instrument, Interest Rate During Period
Interest expense, debt
Interest Expense, Debt
Interest paid on term loan
Interest Paid
Interest expense accreted to balance
Amortization of Financing Costs
Capacity available for specific purpose other than for trade purchases
Line of Credit Facility, Capacity Available for Specific Purpose Other than for Trade Purchases
Additional borrowing capacity
Line of Credit Facility, Additional Borrowing Capacity
Line of Credit Facility, Additional Borrowing Capacity
Minimum cash requirement
Line of Credit Facility, Minimum Cash Requirement
Line of Credit Facility, Minimum Cash Requirement
Potential increase in interest rate
Line of Credit Facility, Debt Default, Increase in Interest Rate
Line of Credit Facility, Debt Default, Increase in Interest Rate
Costs incurred
Debt Issuance Cost
Fees and expenses
Debt Instrument, Fee Amount
Fair value of warrant
Warrants and Rights Outstanding
Remaining borrowing capacity
Line of Credit Facility, Remaining Borrowing Capacity
Fair Value Disclosures [Abstract]
Warrant liability at December 31, 2016
Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value
Increase in fair value of warrant liability
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings
Warrant liability at March 31, 2017
Document and Entity Information [Abstract]
Document and Entity Information [Abstract]
Entity Registrant Name
Entity Registrant Name
Entity Central Index Key
Entity Central Index Key
Current Fiscal Year End Date
Current Fiscal Year End Date
Entity Filer Category
Entity Filer Category
Trading Symbol
Trading Symbol
Document Type
Document Type
Document Period End Date
Document Period End Date
Document Fiscal Year Focus
Document Fiscal Year Focus
Document Fiscal Period Focus
Document Fiscal Period Focus
Amendment Flag
Amendment Flag
Entity Common Stock, Shares Outstanding
Entity Common Stock, Shares Outstanding
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Procurement Contract [Table]
Procurement Contract [Table]
Procurement Contract [Table]
Procurement Contract [Axis]
Procurement Contract [Axis]
Procurement Contract [Axis]
Procurement Contract [Domain]
Procurement Contract [Domain]
Procurement Contract [Domain]
BARDA Contract
Barda Contract [Member]
Barda Contract [Member]
Procurement Contract [Line Items]
Procurement Contract [Line Items]
Procurement Contract [Line Items]
Payments for legal settlements
Payments for Legal Settlements
Proceeds from manufacture and physical delivery of courses, government contract
Proceeds From Manufacture And Physical Delivery Of Courses, Government Contracts
Proceeds from manufacture and physical delivery of courses, government contracts.
Government contract, total number of courses required to be delivered
Government Contract, Total Number of Courses Required to Be Delivered
Government Contract, Total Number of Courses Required to Be Delivered
Reduced holdback amount
Reduced holdback amount
Reduced holdback be received from BARDA
Earnings Per Share [Abstract]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]
Antidilutive Securities [Axis]
Antidilutive Securities [Axis]
Antidilutive Securities, Name [Domain]
Antidilutive Securities, Name [Domain]
Stock Options
Employee Stock Option [Member]
Stock-Settled Stock Appreciation Rights
Stock Appreciation Rights (SARs) [Member]
Restricted Stock Units
Restricted Stock Units (RSUs) [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Weighted average
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Restricted stock units
Restricted Stock Units
Restricted Stock Units have been vested but not converted into common stock
Recent Accounting Pronouncements [Abstract]
Recent Accounting Pronouncements [Abstract]
Recent Accounting Pronoucements
New Accounting Pronouncements and Changes in Accounting Principles [Text Block]
Related Party Transactions [Abstract]
Related Party Transactions
Related Party Transactions Disclosure [Text Block]
Statement of Financial Position [Abstract]
Statement [Table]
Statement [Table]
Statement [Line Items]
Statement [Line Items]
ASSETS
Assets [Abstract]
Current assets
Assets, Current [Abstract]
Cash and cash equivalents
Cash and Cash Equivalents, at Carrying Value
Restricted cash and cash equivalents-short term
Restricted Cash and Cash Equivalents, Current
Accounts receivable
Accounts Receivable, Net, Current
Inventory
Inventory, Net
Prepaid expenses and other current assets
Prepaid Expense and Other Assets, Current
Total current assets
Assets, Current
Property, plant and equipment, net
Restricted cash and cash equivalents-long term
Restricted Cash and Cash Equivalents, Noncurrent
Deferred costs
Deferred Costs, Noncurrent
Goodwill
Goodwill
Other assets
Other Assets, Noncurrent
Total assets
Assets
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Liabilities and Equity [Abstract]
Current liabilities
Liabilities, Current [Abstract]
Accounts payable
Accounts Payable, Current
Accrued expenses and other current liabilities
Warrant liability
Total current liabilities
Liabilities, Current
Deferred revenue
Deferred Revenue, Noncurrent
Deferred income tax liability, net
Deferred Tax Liabilities, Net, Noncurrent
Other liabilities
Other Liabilities
Loan payable
Loans Payable
Total liabilities
Liabilities
Commitments and Contingencies
Commitments and Contingencies
Stockholders’ deficit
Stockholders' Equity Attributable to Parent [Abstract]
Common stock ($.0001 par value, 600,000,000 shares authorized, 78,780,059 and 78,692,612issued and outstanding at March 31, 2017, and December 31, 2016, respectively)
Common Stock, Value, Issued
Additional paid-in capital
Additional Paid in Capital, Common Stock
Accumulated deficit
Retained Earnings (Accumulated Deficit)
Total stockholders’ deficit
Stockholders' Equity Attributable to Parent
Total liabilities and stockholders’ deficit
Liabilities and Equity
Statement of Cash Flows [Abstract]
Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]
Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]
Cash flows from operating activities:
Net Cash Provided by (Used in) Operating Activities [Abstract]
Net loss
Net Income (Loss) Attributable to Parent
Adjustments to reconcile net loss to net cash (used in) operating activities:
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Depreciation and other amortization
Increase in fair value of warrant liability
Increase In Fair Value Of Warrants
Noncash expense, not otherwise specified in the taxonomy, charged against earnings in the period to adjust the fair market value of liability classified warrants to purchase common stock.
Stock-based compensation
Share-based Compensation
Non-cash interest expense
Other Noncash Expense
Interest expense on term loan - paid with restricted cash
Payment of Interest Expense
Payment of Interest Expense
Changes in assets and liabilities:
Increase (Decrease) in Operating Capital [Abstract]
Accounts receivable
Increase (Decrease) in Accounts Receivable
Inventory
Increase (Decrease) in Inventories
Deferred costs
Increase (Decrease) in Deferred Charges
Prepaid expenses and other current assets
Increase (Decrease) in Prepaid Expense
Deferred income taxes, net
Deferred Income Tax Expense (Benefit)
Accounts payable, accrued expenses and other current liabilities
Increase (Decrease) in Accounts Payable and Accrued Liabilities
Liabilities subject to compromise
Liabilities Subject to Compromise, Period Increase (Decrease)
Deferred revenue
Increase (Decrease) in Deferred Revenue
Other liabilities
Increase (Decrease) in Other Operating Liabilities
Net cash provided by (used in) operating activities
Net Cash Provided by (Used in) Operating Activities
Cash flows from investing activities:
Net Cash Provided by (Used in) Investing Activities [Abstract]
Capital expenditures
Payments to Acquire Property, Plant, and Equipment
Net cash provided by (used in) investing activities
Net Cash Provided by (Used in) Investing Activities
Cash flows from financing activities:
Net Cash Provided by (Used in) Financing Activities [Abstract]
Payment of employee tax obligations for common stock tendered
Payments Related to Tax Withholding for Share-based Compensation
Net cash used by financing activities
Net Cash Provided by (Used in) Financing Activities
Net increase (decrease) in cash and cash equivalents
Cash and Cash Equivalents, Period Increase (Decrease)
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental Cash Flow Information [Abstract]
Supplemental Cash Flow Information [Abstract]
Cash interest paid on Term Loan from restricted cash
Interest Paid on Term Loan From Restricted Cash
Interest Paid on Term Loan From Restricted Cash
Income Tax Disclosure [Abstract]
Current income tax expense (benefit)
Current Income Tax Expense (Benefit)
Income (loss) from continuing operations before income taxes
Income (Loss) from Continuing Operations before Income Taxes, Domestic
Commitments and Contingencies Disclosure [Abstract]
Loss Contingencies [Table]
Loss Contingencies [Table]
Litigation Case [Axis]
Litigation Case [Axis]
Litigation Case Type [Domain]
Litigation Case [Domain]
License Agreement litigation
License Agreement Litigation [Member]
License Agreement Litigation [Member]
Litigation Status [Axis]
Litigation Status [Axis]
Litigation Status [Domain]
Litigation Status [Domain]
Settled Litigation
Settled Litigation [Member]
Loss Contingencies [Line Items]
Loss Contingencies [Line Items]
Number of courses to be delivered
Number of Courses To Be Delivered 1
Number of tecovirimat, also known as ST-246, courses to be delivered to the U.S. Strategic National Stockpile
Final order and judgment
Final Order And Judgment
Final order and judgment entered by the Court awarding damages to the Plaintiff.
Final order and judgment post-judgment interest
Final Order And Judgment Post-Judgment Interest
Final order and judgment post-judgment interest entered by the Court awarding damages to the Plaintiff.
Final order and judgment including interest
Final order and judgment plus interest
Final Order and Judgment entered by the Court awarding expectation damages, plus pre-judgment interest, and certain permitted legal fees, costs, and expenses to Plaintiff.
Per Share Data
Earnings Per Share [Text Block]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
Equity [Abstract]
Financial Instruments
Financial Instruments Disclosure [Text Block]
Condensed Consolidated Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
Balance Sheet Parenthetical [Abstract]
Balance Sheet Parenthetical [Abstract]
Common stock, par value
Common Stock, Par or Stated Value Per Share
Common stock, shares authorized
Common Stock, Shares Authorized
Common stock, shares issued
Common Stock, Shares, Issued
Common stock, shares outstanding
Common Stock, Shares, Outstanding
Property, plant and equipment
Property, Plant and Equipment [Table Text Block]
Schedule of Related Party Transactions, by Related Party [Table]
Schedule of Related Party Transactions, by Related Party [Table]
Sale of Stock [Axis]
Sale of Stock [Axis]
Sale of Stock [Domain]
Sale of Stock [Domain]
Private Placement
Private Placement [Member]
Related Party [Axis]
Related Party [Axis]
Related Party [Domain]
Related Party [Domain]
Member of Board of Directors
Management [Member]
Affiliated Entity
Affiliated Entity [Member]
Related Party Transaction [Line Items]
Related Party Transaction [Line Items]
Legal fees
Legal Fees
Accounts payable to related party
Accounts Payable, Related Parties
Share price
Share Price
Free rent period
Free Rent Period
Free Rent Period in months allowed under the sublease.
Monthly rental payments first five years
Monthly Rental Payments First Five Years
The amount of the monthly rental payments due under the sublease entered into for the first five years.
Initial rent period
Initial Rent Period
Represents the number of years for the initial rent period of five years and related monthly payments.
Monthly rental payments after five years
Monthly Rental Payments After Five Years
The amount of the monthly rental payments due under the sublease entered into after the first five years.
Rent period after first five years
Rent Period After First Five Years
Represents the amount of years after the initial rent period of first five years of which monthly rental payments will increase.
Inventory [Abstract]
Inventory [Abstract]
Inventory
Schedule of Inventory, Current [Table Text Block]
Class of Warrant or Right [Table]
Class of Warrant or Right [Table]
Class of Stock [Axis]
Class of Stock [Axis]
Class of Stock [Domain]
Class of Stock [Domain]
Common Stock
Common Stock [Member]
Class of Warrant or Right [Axis]
Class of Warrant or Right [Axis]
Class of Warrant or Right [Domain]
Class of Warrant or Right [Domain]
Equity Rights
Equity Rights [Member]
Equity Rights [Member]
Subscription Right
Subscription Right [Member]
Subscription Right [Member]
Class of Warrant or Right [Line Items]
Class of Warrant or Right [Line Items]
Warrants to purchase common stock
Class of Warrant or Right, Number of Securities Called by Warrants or Rights
Exercise price of warrants to purchase common stock
Class of Warrant or Right, Exercise Price of Warrants or Rights
Exercisable period for warrants (in years)
Class of Warrant or Right, Period from which Warrants or Rights are Exercisable
Class of Warrant or Right, Period from which Warrants or Rights are Exercisable
Risk free interest rate (as a percent)
Fair Value Assumptions, Risk Free Interest Rate
Expected dividend rate (as a percent)
Fair Value Assumptions, Expected Dividend Rate
Expected term (in years)
Fair Value Assumptions, Expected Term
Expected volatility rate (as a percent)
Fair Value Assumptions, Expected Volatility Rate
Equity offering
Proceeds from Issuance of Warrants
Issuance of common stock associated with rights offering, shares
Stock Issued During Period, Shares, Rights Offering
Stock Issued During Period, Shares, Rights Offering
Warrants that can be purchased, shares
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right
Amount to be invested by each warrant or right to purchase securities, per share
Class of Warrant or Right, Amount to be Invested by Each Warrant or Right to Purchase Securities, Per Share
Class of Warrant or Right, Amount to be Invested by Each Warrant or Right to Purchase Securities, Per Share
Volume of weighted average price during market hours (as a percent)
Class of Warrant or Right, Exercise Price of Warrants or Rights, Volume of Weighted Average Price During Market Hours, Percentage
Class of Warrant or Right, Exercise Price of Warrants or Rights, Volume of Weighted Average Price During Market Hours, Percentage
Stock issued during period, new issues, shares
Stock Issued During Period, Shares, New Issues
Payments of stock issuance costs
Payments of Stock Issuance Costs
Value of contract
Government Contract, Value of Award 1
Value of base contract award.
Contract Value of Manufacturing and Delivery Activities
Contract Value of Manufacturing and Delivery Activities
Contract value of manufacturing and delivery activities.
Contract value of development and support activities
Contract Value of Development and Support Activities
Contract value of development and support activities
Contract value of various options
Contract Value of Various Options
Contract value of various options exercisable at BARDA's discretion.
Number of courses under modified contract
Government Contract, Number of Courses Purchased Under Modified Contract
Government contract, number of courses to be purchased under modified contract.
Government contract, number of free courses
Government Contract, Number of Free Courses
Number of courses of tecovirimat to be contributed to the Strategic Stockpile at no cost to the government.
Proceeds from advance payments under the BARDA contract
Proceeds from Advance Payments, Government Contracts
Proceeds from advance payments, government contracts
Milestone payment
Milestone payment
Proceeds from milestone payment, Government contracts
Proceeds From Physical Delivery Of Courses, Government Contracts
Proceeds From Physical Delivery Of Courses, Government Contracts
Proceeds from physical delivery of courses, government contract.
Number of courses delivered and accepted at provisional dosage, once daily
Number Of Courses Delivered And Accepted At Provisional Dosage, Once Daily
Number of tecovirimat, also known as ST-246, courses delivered and accepted at the provisional dosage of 600 mg once daily to the U.S. Strategic National Stockpile.
Research and development revenue long-term contract
Research and Development Revenue Long-term Contract
Revenue earned during the period arising from research and development services provided under the terms of a long-term contract. May include government contracts and any other contract related to a particular project or product.
Number of active grants
Number of Active Grants
Number of active grants
Potential future research and development funding
Potential Future Aggregate Research and Development Expenses
Potential future aggregate research and development funding for specific projects which includes options that may or may not be exercised at the U.S. government's discretion.
Contract Value, Option, FDA Approval
Contract Value, Option, FDA Approval
Contract value of option exercisable, FDA approval for extension to 84-month expiry for Tecovirimat, at BARDA's discretion.
Contract Value, Detail Of Option Exercisable, Development Activities
Contract Value, Detail Of Option Exercisable, Development Activities
Contract value of option exercisable, amount represents exercisable option that would fund development and support activities, at BARDA's discretion.
Contract Value, Detail Of Option Exercisable, Production Activities
Contract Value, Detail Of Option Exercisable, Production Activities
Contract value of option exercisable, amount represents exercisable option that would fund production activities, at BARDA's discretion.
Increase in payments for delivery of courses of TPOXX
Increase in payments for delivery of courses of TPOXX
Increase in payments for delivery of courses of TPOXX
Holdback amount pending FDA approval
Holdback amount pending FDA approval
Holdback amount pending FDA approval
Number of courses to be delivered by company
Number of Courses to be Delivered by Company
Number of Courses to be Delivered by Company
Amount of option to be received from BARDA for approval for extension of 84 moth expiry
Amount of option to be received from BARDA for approval for extension of 84 moth expiry
Amount of option to be received from BARDA for approval for extension of 84 moth expiry
Deferred revenue
Deferred Revenue
Increase to funding of research and development contract
Increase to Funding of Research and Development Contract
Increase to Funding of Research and Development Contract
Fair Value Measurements, Recurring and Nonrecurring [Table]
Fair Value Measurements, Recurring and Nonrecurring [Table]
Measurement Frequency [Axis]
Measurement Frequency [Axis]
Fair Value, Measurement Frequency [Domain]
Fair Value, Measurement Frequency [Domain]
Fair Value, Measurements, Recurring
Fair Value, Measurements, Recurring [Member]
Long-term Debt, Type [Axis]
Long-term Debt, Type [Axis]
Long-term Debt, Type [Domain]
Long-term Debt, Type [Domain]
Senior Secured Term Loan
Senior Secured Term Loan [Member]
Senior Secured Term Loan [Member]
Fair Value, Hierarchy [Axis]
Fair Value, Hierarchy [Axis]
Fair Value Hierarchy [Domain]
Fair Value Hierarchy [Domain]
Fair Value, Inputs, Level 2
Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loan outstanding
Long-term Debt
Schedule of antidilutive securities excluded from computation of earnings per share
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Inventory Disclosure [Abstract]
Work in process
Inventory, Work in Process and Raw Materials
Finished goods
Inventory, Finished Goods, Net of Reserves
Inventory write-downs
Inventory Write-downs
Inventory write-downs included in research and development expense on the balance sheet.
Reorganization payments
Reorganization Payments
The amount the Company paid for reorganization items.
Accrued Expenses
Accrued expenses and other current liabilities [Table Text Block]
Tabular disclosure of the components of accrued liabilities and other current liabilities.
Legal fees
Debtor Reorganization Items, Legal and Advisory Professional Fees
Professional fees
Reorganization, Professional Fees
Amount of reorganization items related to professional fees related to entities in bankruptcy.
Trustee fees
Reorganization, Trustee fees
Amount of reorganization items for trustee fees related to entities in bankruptcy.
Total
Reorganization Items
Inventory
Inventory Disclosure [Text Block]
Fair Value Measurements [Abstract]
Fair Value Measurements [Abstract]
Fair Value of Financial Instruments
Fair Value Disclosures [Text Block]
Debt
Debt Disclosure [Text Block]
Property, Plant and Equipment
Property, Plant and Equipment Disclosure [Text Block]
Income Taxes
Income Tax Disclosure [Text Block]
Commitments and Contingencies
Commitments and Contingencies Disclosure [Text Block]
Income Statement [Abstract]
Revenues
Revenues [Abstract]
Research and development
Research and Development Revenue
Revenue earned during the period arising from services provided under the terms of a contract, not elsewhere specified in the taxonomy. May include government contracts and any other contract related to a particular project or product.
Operating expenses
Operating Expenses [Abstract]
Selling, general and administrative
Selling, General and Administrative Expense
Research and development
Research and Development Expense
Patent preparation fees
Patent Preparation Fees
The aggregate costs incurred for fees associated with the protection and expansion of patents and related intellectual property.
Interest on PharmAthene liability
Litigation Settlement Interest
Total operating expenses
Operating Expenses
Operating loss
Operating Income (Loss)
Decrease (increase) in fair value warrant liability
Interest expense
Interest Expense
Other income, net
Nonoperating Income (Expense)
Reorganization items, net
Loss before income taxes
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest
Provision for income taxes
Income Tax Expense (Benefit)
Net and comprehensive loss
Loss per share: basic and diluted
Earnings Per Share, Basic and Diluted
Weighted average shares outstanding: basic and diluted
Weighted Average Number of Shares Outstanding, Basic and Diluted
New Accounting Pronouncements or Change in Accounting Principle [Table]
New Accounting Pronouncements or Change in Accounting Principle [Table]
Adjustments for New Accounting Pronouncements [Axis]
Adjustments for New Accounting Pronouncements [Axis]
Type of Adoption [Domain]
Type of Adoption [Domain]
Accounting Standards Update 2016-09
Accounting Standards Update 2016-09 [Member]
Accounting Standards Update 2016-09 [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative effect of new accounting principle in period of adoption
Deferred Income Tax Assets, Net